Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Lineage Cell Therapeutics Inc Share Price

LCTX

ASQ

$1.72

+$0.04

(2.38%)

Industry: Biotechnology Sector: Health Care

Lineage Cell Therapeutics Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Lineage Cell Therapeutics Inc Share Price Chart

Lineage Cell Therapeutics Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$386.95M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

501.75K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

1.80

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$0.37 L

$2.09 H

$1.72

About Lineage Cell Therapeutics Inc, Common Stock

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the age-related macular degeneration; OPC1, an allogeneic oligodendrocyte progenitor cell therapy that is in Phase 1/2a multicenter clinical trial for the treatment of cervical spinal cord injuries; and VAC2, which is in Phase I clinical trial to treat non-small cell lung cancer. It also offers ReSonance (ANP1), an allogeneic auditory neuron progenitor cell transplant, which is in preclinical development for the treatment of sensorineural hearing loss; and PNC1, an allogeneic photoreceptor cell transplant, which is in preclinical development for the treatment of vision loss due to photoreceptor dysfunction or damage. In addition, the company is developing RND1, a cell transplant program for an undisclosed indication through a gene editing collaboration, engages in the research and development of therapeutic products for retinal diseases, neurological diseases, and disorders and oncology. Lineage Cell Therapeutics, Inc. has a collaboration with Immunomic Therapeutics, Inc., for the treatment of glioblastoma multiforme. The company also has a strategic collaboration with Factor Bioscience Inc. for the development of genetically engineered iPSC line for the company to utilize for differentiation into certain cell transplant product candidates. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was incorporated in 1990 and is headquartered in Carlsbad, California. more

Industry: BiotechnologySector: Health Care

Lineage Cell Therapeutics Inc Stock Returns

Time Frame	LCTX	Sector	S&P500
1-Week Return	-4.44%	0.72%	-1.31%
1-Month Return	4.24%	1.27%	0.78%
3-Month Return	-2.82%	3.13%	3.46%
6-Month Return	34.37%	15.81%	6.19%
1-Year Return	137.27%	8.89%	11.68%
3-Year Return	36.51%	20.79%	71.21%
5-Year Return	-39.65%	35.89%	74.81%
10-Year Return	-15.83%	138.44%	256.59%

Time Frame	LCTX	Sector	S&P500
1-Week Return	-90.63%	45.37%	-49.72%
1-Month Return	65.74%	16.60%	9.91%
3-Month Return	-10.95%	13.31%	14.79%
6-Month Return	82.04%	34.67%	12.95%
1-Year Return	137.27%	8.89%	11.68%
3-Year Return	10.93%	6.50%	19.63%
5-Year Return	-9.61%	6.33%	11.82%
10-Year Return	-1.71%	9.08%	13.56%

Lineage Cell Therapeutics Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	773.00K	3.90M	14.70M	8.95M	9.50M	[{"date":"2020-12-31","value":5.26,"profit":true},{"date":"2021-12-31","value":26.5,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":60.84,"profit":true},{"date":"2024-12-31","value":64.61,"profit":true}]
Cost of Revenue	385.00K	1.43M	728.00K	671.00K	334.00K	[{"date":"2020-12-31","value":27,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":51.05,"profit":true},{"date":"2023-12-31","value":47.05,"profit":true},{"date":"2024-12-31","value":23.42,"profit":true}]
Gross Profit	388.00K	2.47M	13.97M	8.27M	9.16M	[{"date":"2020-12-31","value":2.78,"profit":true},{"date":"2021-12-31","value":17.67,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":59.21,"profit":true},{"date":"2024-12-31","value":65.58,"profit":true}]
Gross Margin	50.19%	63.40%	95.05%	92.50%	96.48%	[{"date":"2020-12-31","value":52.02,"profit":true},{"date":"2021-12-31","value":65.71,"profit":true},{"date":"2022-12-31","value":98.51,"profit":true},{"date":"2023-12-31","value":95.87,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Operating Expenses	26.84M	51.68M	36.49M	33.01M	30.64M	[{"date":"2020-12-31","value":51.92,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":70.62,"profit":true},{"date":"2023-12-31","value":63.87,"profit":true},{"date":"2024-12-31","value":59.29,"profit":true}]
Operating Income	(26.45M)	(49.21M)	(22.52M)	(24.73M)	(21.48M)	[{"date":"2020-12-31","value":-2644700000,"profit":false},{"date":"2021-12-31","value":-4921100000,"profit":false},{"date":"2022-12-31","value":-2252000000,"profit":false},{"date":"2023-12-31","value":-2473300000,"profit":false},{"date":"2024-12-31","value":-2147800000,"profit":false}]
Total Non-Operating Income/Expense	5.56M	5.94M	(2.46M)	3.08M	4.61M	[{"date":"2020-12-31","value":93.59,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-41.44,"profit":false},{"date":"2023-12-31","value":51.83,"profit":true},{"date":"2024-12-31","value":77.59,"profit":true}]
Pre-Tax Income	(21.92M)	(43.27M)	(25.81M)	(23.28M)	(18.58M)	[{"date":"2020-12-31","value":-2192400000,"profit":false},{"date":"2021-12-31","value":-4327000000,"profit":false},{"date":"2022-12-31","value":-2581200000,"profit":false},{"date":"2023-12-31","value":-2328200000,"profit":false},{"date":"2024-12-31","value":-1858200000,"profit":false}]
Income Taxes	(1.24M)	(4.71M)	541.00K	(1.80M)	27.00K	[{"date":"2020-12-31","value":-229.02,"profit":false},{"date":"2021-12-31","value":-869.87,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-333.27,"profit":false},{"date":"2024-12-31","value":4.99,"profit":true}]
Income After Taxes	(20.68M)	(38.56M)	(26.35M)	(21.48M)	(18.61M)	[{"date":"2020-12-31","value":-2068500000,"profit":false},{"date":"2021-12-31","value":-3856400000,"profit":false},{"date":"2022-12-31","value":-2635300000,"profit":false},{"date":"2023-12-31","value":-2147900000,"profit":false},{"date":"2024-12-31","value":-1860900000,"profit":false}]

Income From Continuous Operations	(20.68M)	(43.27M)	(26.35M)	(21.48M)	(18.58M)	[{"date":"2020-12-31","value":-2068500000,"profit":false},{"date":"2021-12-31","value":-4327000000,"profit":false},{"date":"2022-12-31","value":-2635300000,"profit":false},{"date":"2023-12-31","value":-2147900000,"profit":false},{"date":"2024-12-31","value":-1858200000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(20.65M)	(43.02M)	(26.27M)	(21.49M)	(18.61M)	[{"date":"2020-12-31","value":-2064900000,"profit":false},{"date":"2021-12-31","value":-4301900000,"profit":false},{"date":"2022-12-31","value":-2627300000,"profit":false},{"date":"2023-12-31","value":-2148600000,"profit":false},{"date":"2024-12-31","value":-1860900000,"profit":false}]

EPS (Diluted)	(0.14)	(0.26)	(0.15)	(0.13)	(0.10)	[{"date":"2020-12-31","value":-14,"profit":false},{"date":"2021-12-31","value":-26,"profit":false},{"date":"2022-12-31","value":-15,"profit":false},{"date":"2023-12-31","value":-13,"profit":false},{"date":"2024-12-31","value":-10,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	404.01%	277.39%	(39.16%)	6.19%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":68.66,"profit":true},{"date":"2023-12-31","value":-9.69,"profit":false},{"date":"2024-12-31","value":1.53,"profit":true}]
Cost of Revenue	-	270.39%	(48.95%)	(7.83%)	(50.22%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-18.1,"profit":false},{"date":"2023-12-31","value":-2.9,"profit":false},{"date":"2024-12-31","value":-18.57,"profit":false}]
Gross Profit	-	536.60%	465.79%	(40.79%)	10.77%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":86.8,"profit":true},{"date":"2023-12-31","value":-7.6,"profit":false},{"date":"2024-12-31","value":2.01,"profit":true}]
Gross Margin	-	26.31%	49.92%	(2.68%)	4.31%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":52.69,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-5.37,"profit":false},{"date":"2024-12-31","value":8.63,"profit":true}]

Operating Expenses	-	92.59%	(29.38%)	(9.56%)	(7.16%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-31.74,"profit":false},{"date":"2023-12-31","value":-10.32,"profit":false},{"date":"2024-12-31","value":-7.74,"profit":false}]
Operating Income	-	86.07%	(54.24%)	9.83%	(13.16%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-63.01,"profit":false},{"date":"2023-12-31","value":11.42,"profit":true},{"date":"2024-12-31","value":-15.29,"profit":false}]
Total Non-Operating Income/Expense	-	6.85%	(141.44%)	(225.05%)	49.71%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":13.78,"profit":true},{"date":"2022-12-31","value":-284.55,"profit":false},{"date":"2023-12-31","value":-452.75,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	-	97.36%	(40.35%)	(9.80%)	(20.19%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-41.44,"profit":false},{"date":"2023-12-31","value":-10.07,"profit":false},{"date":"2024-12-31","value":-20.73,"profit":false}]
Income Taxes	-	279.82%	(111.50%)	(433.27%)	(101.50%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-39.85,"profit":false},{"date":"2023-12-31","value":-154.84,"profit":false},{"date":"2024-12-31","value":-36.27,"profit":false}]
Income After Taxes	-	86.43%	(31.66%)	(18.50%)	(13.36%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-36.63,"profit":false},{"date":"2023-12-31","value":-21.4,"profit":false},{"date":"2024-12-31","value":-15.46,"profit":false}]

Income From Continuous Operations	-	109.19%	(39.10%)	(18.50%)	(13.49%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-35.81,"profit":false},{"date":"2023-12-31","value":-16.94,"profit":false},{"date":"2024-12-31","value":-12.35,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	108.33%	(38.93%)	(18.22%)	(13.39%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-35.93,"profit":false},{"date":"2023-12-31","value":-16.82,"profit":false},{"date":"2024-12-31","value":-12.36,"profit":false}]

EPS (Diluted)	-	85.71%	(42.31%)	(13.33%)	(23.08%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-49.36,"profit":false},{"date":"2023-12-31","value":-15.56,"profit":false},{"date":"2024-12-31","value":-26.92,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	3.78M	2.87M	1.50M	2.77M	3.68M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":75.89,"profit":true},{"date":"2025-03-31","value":39.75,"profit":true},{"date":"2025-06-30","value":73.17,"profit":true},{"date":"2025-09-30","value":97.41,"profit":true}]
Cost of Revenue	38.00K	154.00K	36.00K	39.00K	5.00K	[{"date":"2024-09-30","value":24.68,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":23.38,"profit":true},{"date":"2025-06-30","value":25.32,"profit":true},{"date":"2025-09-30","value":3.25,"profit":true}]
Gross Profit	3.74M	2.71M	1.47M	2.73M	3.68M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":72.55,"profit":true},{"date":"2025-03-31","value":39.19,"profit":true},{"date":"2025-06-30","value":72.87,"profit":true},{"date":"2025-09-30","value":98.26,"profit":true}]
Gross Margin	98.99%	94.63%	97.60%	98.59%	99.86%	[{"date":"2024-09-30","value":99.13,"profit":true},{"date":"2024-12-31","value":94.76,"profit":true},{"date":"2025-03-31","value":97.74,"profit":true},{"date":"2025-06-30","value":98.72,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Operating Expenses	7.58M	7.82M	7.97M	22.51M	7.46M	[{"date":"2024-09-30","value":33.68,"profit":true},{"date":"2024-12-31","value":34.76,"profit":true},{"date":"2025-03-31","value":35.42,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":33.16,"profit":true}]
Operating Income	(3.84M)	(5.11M)	(6.50M)	(19.78M)	(3.79M)	[{"date":"2024-09-30","value":-384000000,"profit":false},{"date":"2024-12-31","value":-511000000,"profit":false},{"date":"2025-03-31","value":-650500000,"profit":false},{"date":"2025-06-30","value":-1978000000,"profit":false},{"date":"2025-09-30","value":-378600000,"profit":false}]
Total Non-Operating Income/Expense	1.24M	2.25M	2.84M	(10.13M)	(25.60M)	[{"date":"2024-09-30","value":43.52,"profit":true},{"date":"2024-12-31","value":79.33,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-356.69,"profit":false},{"date":"2025-09-30","value":-901.41,"profit":false}]
Pre-Tax Income	(3.00M)	(3.25M)	(4.14M)	(30.36M)	(29.75M)	[{"date":"2024-09-30","value":-300100000,"profit":false},{"date":"2024-12-31","value":-325000000,"profit":false},{"date":"2025-03-31","value":-414300000,"profit":false},{"date":"2025-06-30","value":-3036400000,"profit":false},{"date":"2025-09-30","value":-2975200000,"profit":false}]
Income Taxes	33.00K	10.00K	-	-	-	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":30.3,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	(3.03M)	(3.26M)	-	-	-	[{"date":"2024-09-30","value":-303400000,"profit":false},{"date":"2024-12-31","value":-326000000,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	(3.00M)	(3.25M)	(4.14M)	(30.36M)	(29.75M)	[{"date":"2024-09-30","value":-300100000,"profit":false},{"date":"2024-12-31","value":-325000000,"profit":false},{"date":"2025-03-31","value":-414300000,"profit":false},{"date":"2025-06-30","value":-3036400000,"profit":false},{"date":"2025-09-30","value":-2975200000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(3.03M)	(3.27M)	(4.14M)	(30.46M)	(29.78M)	[{"date":"2024-09-30","value":-303400000,"profit":false},{"date":"2024-12-31","value":-327300000,"profit":false},{"date":"2025-03-31","value":-413900000,"profit":false},{"date":"2025-06-30","value":-3046400000,"profit":false},{"date":"2025-09-30","value":-2978100000,"profit":false}]

EPS (Diluted)	(0.02)	(0.01)	(0.02)	(0.13)	(0.13)	[{"date":"2024-09-30","value":-2,"profit":false},{"date":"2024-12-31","value":-1,"profit":false},{"date":"2025-03-31","value":-2,"profit":false},{"date":"2025-06-30","value":-13,"profit":false},{"date":"2025-09-30","value":-13,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	(24.11%)	(47.63%)	84.09%	33.13%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-28.67,"profit":false},{"date":"2025-03-31","value":-56.64,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":39.4,"profit":true}]
Cost of Revenue	-	305.26%	(76.62%)	8.33%	(87.18%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-25.1,"profit":false},{"date":"2025-06-30","value":2.73,"profit":true},{"date":"2025-09-30","value":-28.56,"profit":false}]
Gross Profit	-	(27.45%)	(45.98%)	85.95%	34.85%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-31.94,"profit":false},{"date":"2025-03-31","value":-53.5,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":40.55,"profit":true}]
Gross Margin	-	(4.41%)	3.14%	1.01%	1.29%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-140.33,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":32.17,"profit":true},{"date":"2025-09-30","value":41.16,"profit":true}]

Operating Expenses	-	3.21%	1.88%	182.35%	(66.84%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":1.76,"profit":true},{"date":"2025-03-31","value":1.03,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-36.66,"profit":false}]
Operating Income	-	33.07%	27.30%	204.07%	(80.86%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":16.21,"profit":true},{"date":"2025-03-31","value":13.38,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-39.62,"profit":false}]
Total Non-Operating Income/Expense	-	82.28%	26.05%	(456.69%)	152.71%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":53.88,"profit":true},{"date":"2025-03-31","value":17.06,"profit":true},{"date":"2025-06-30","value":-299.05,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Pre-Tax Income	-	8.30%	27.48%	632.90%	(2.02%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":1.31,"profit":true},{"date":"2025-03-31","value":4.34,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-0.32,"profit":false}]
Income Taxes	-	(69.70%)	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	7.45%	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	8.30%	27.48%	632.90%	(2.02%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":1.31,"profit":true},{"date":"2025-03-31","value":4.34,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-0.32,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	7.88%	26.46%	636.02%	(2.24%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":1.24,"profit":true},{"date":"2025-03-31","value":4.16,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-0.35,"profit":false}]

EPS (Diluted)	-	(50.00%)	100.00%	550.00%	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-9.09,"profit":false},{"date":"2025-03-31","value":18.18,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":"-","profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	44.00M	111.55M	60.00M	38.44M	51.00M	[{"date":"2020-12-31","value":39.44,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":53.79,"profit":true},{"date":"2023-12-31","value":34.46,"profit":true},{"date":"2024-12-31","value":45.72,"profit":true}]
Non-current Assets	63.95M	63.00M	63.66M	62.58M	62.22M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":98.51,"profit":true},{"date":"2022-12-31","value":99.55,"profit":true},{"date":"2023-12-31","value":97.85,"profit":true},{"date":"2024-12-31","value":97.3,"profit":true}]
Total Assets	107.95M	174.54M	123.66M	101.02M	113.22M	[{"date":"2020-12-31","value":61.85,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":70.85,"profit":true},{"date":"2023-12-31","value":57.88,"profit":true},{"date":"2024-12-31","value":64.86,"profit":true}]

Total Liabilities
Current Liabilities	7.77M	47.12M	18.98M	17.96M	13.98M	[{"date":"2020-12-31","value":16.49,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":40.29,"profit":true},{"date":"2023-12-31","value":38.12,"profit":true},{"date":"2024-12-31","value":29.67,"profit":true}]
Non-current Liabilities	5.05M	36.53M	32.75M	21.04M	22.23M	[{"date":"2020-12-31","value":13.83,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.64,"profit":true},{"date":"2023-12-31","value":57.58,"profit":true},{"date":"2024-12-31","value":60.85,"profit":true}]
Total Liabilities	12.82M	83.65M	51.73M	39.00M	36.21M	[{"date":"2020-12-31","value":15.33,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":61.84,"profit":true},{"date":"2023-12-31","value":46.62,"profit":true},{"date":"2024-12-31","value":43.28,"profit":true}]

Total Shareholders' equity
Common Stock	393.94M	434.53M	440.28M	451.34M	484.72M	[{"date":"2020-12-31","value":81.27,"profit":true},{"date":"2021-12-31","value":89.64,"profit":true},{"date":"2022-12-31","value":90.83,"profit":true},{"date":"2023-12-31","value":93.11,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(294.08M)	(337.10M)	(363.37M)	(384.86M)	(403.46M)	[{"date":"2020-12-31","value":-29407800000,"profit":false},{"date":"2021-12-31","value":-33709700000,"profit":false},{"date":"2022-12-31","value":-36337000000,"profit":false},{"date":"2023-12-31","value":-38485600000,"profit":false},{"date":"2024-12-31","value":-40346500000,"profit":false}]
Other Stockholders' Equity	(3.67M)	433.21M	(3.57M)	(1.40M)	(1.37M)	[{"date":"2020-12-31","value":-0.85,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.82,"profit":false},{"date":"2023-12-31","value":-0.32,"profit":false},{"date":"2024-12-31","value":-0.32,"profit":false}]
Total Shareholders' equity	96.20M	92.22M	73.34M	63.42M	78.38M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":95.86,"profit":true},{"date":"2022-12-31","value":76.24,"profit":true},{"date":"2023-12-31","value":65.92,"profit":true},{"date":"2024-12-31","value":81.48,"profit":true}]

Total Liabilities & Shareholders Equity	109.02M	175.87M	125.07M	102.42M	114.59M	[{"date":"2020-12-31","value":61.99,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":71.11,"profit":true},{"date":"2023-12-31","value":58.23,"profit":true},{"date":"2024-12-31","value":65.16,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	153.53%	(46.21%)	(35.93%)	32.66%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-30.1,"profit":false},{"date":"2023-12-31","value":-23.4,"profit":false},{"date":"2024-12-31","value":21.28,"profit":true}]
Non-current Assets	-	(1.49%)	1.06%	(1.71%)	(0.57%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-140.68,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-160.87,"profit":false},{"date":"2024-12-31","value":-53.8,"profit":false}]
Total Assets	-	61.69%	(29.15%)	(18.31%)	12.08%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-47.25,"profit":false},{"date":"2023-12-31","value":-29.68,"profit":false},{"date":"2024-12-31","value":19.57,"profit":true}]

Total Liabilities
Current Liabilities	-	506.46%	(59.71%)	(5.38%)	(22.18%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-11.79,"profit":false},{"date":"2023-12-31","value":-1.06,"profit":false},{"date":"2024-12-31","value":-4.38,"profit":false}]
Non-current Liabilities	-	622.96%	(10.36%)	(35.76%)	5.67%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-1.66,"profit":false},{"date":"2023-12-31","value":-5.74,"profit":false},{"date":"2024-12-31","value":0.91,"profit":true}]
Total Liabilities	-	552.37%	(38.16%)	(24.61%)	(7.15%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-6.91,"profit":false},{"date":"2023-12-31","value":-4.46,"profit":false},{"date":"2024-12-31","value":-1.3,"profit":false}]

Total Shareholders' equity
Common Stock	-	10.30%	1.32%	2.51%	7.40%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":12.85,"profit":true},{"date":"2023-12-31","value":24.39,"profit":true},{"date":"2024-12-31","value":71.79,"profit":true}]
Retained Earnings	-	14.63%	7.79%	5.91%	4.84%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":53.28,"profit":true},{"date":"2023-12-31","value":40.42,"profit":true},{"date":"2024-12-31","value":33.05,"profit":true}]
Other Stockholders' Equity	-	(11913.64%)	(100.82%)	(60.91%)	(1.93%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Total Shareholders' equity	-	(4.14%)	(20.47%)	(13.53%)	23.59%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-17.53,"profit":false},{"date":"2022-12-31","value":-86.79,"profit":false},{"date":"2023-12-31","value":-57.33,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	61.32%	(28.89%)	(18.11%)	11.88%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-47.11,"profit":false},{"date":"2023-12-31","value":-29.54,"profit":false},{"date":"2024-12-31","value":19.38,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	34.40M	51.00M	49.98M	43.84M	42.26M	[{"date":"2024-09-30","value":67.46,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":98.01,"profit":true},{"date":"2025-06-30","value":85.97,"profit":true},{"date":"2025-09-30","value":82.87,"profit":true}]
Non-current Assets	62.19M	62.22M	61.77M	46.95M	47.38M	[{"date":"2024-09-30","value":99.95,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":99.27,"profit":true},{"date":"2025-06-30","value":75.46,"profit":true},{"date":"2025-09-30","value":76.15,"profit":true}]
Total Assets	96.59M	113.22M	111.75M	90.80M	89.64M	[{"date":"2024-09-30","value":85.32,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":98.71,"profit":true},{"date":"2025-06-30","value":80.2,"profit":true},{"date":"2025-09-30","value":79.17,"profit":true}]

Total Liabilities
Current Liabilities	13.86M	13.98M	13.09M	10.76M	9.38M	[{"date":"2024-09-30","value":99.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":93.65,"profit":true},{"date":"2025-06-30","value":76.95,"profit":true},{"date":"2025-09-30","value":67.12,"profit":true}]
Non-current Liabilities	17.94M	22.23M	21.01M	32.93M	59.46M	[{"date":"2024-09-30","value":30.16,"profit":true},{"date":"2024-12-31","value":37.38,"profit":true},{"date":"2025-03-31","value":35.33,"profit":true},{"date":"2025-06-30","value":55.38,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Liabilities	31.80M	36.21M	34.10M	43.69M	68.84M	[{"date":"2024-09-30","value":46.19,"profit":true},{"date":"2024-12-31","value":52.59,"profit":true},{"date":"2025-03-31","value":49.53,"profit":true},{"date":"2025-06-30","value":63.46,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	469.27M	484.72M	489.31M	490.55M	494.18M	[{"date":"2024-09-30","value":94.96,"profit":true},{"date":"2024-12-31","value":98.09,"profit":true},{"date":"2025-03-31","value":99.02,"profit":true},{"date":"2025-06-30","value":99.27,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(400.19M)	(403.46M)	(407.60M)	(438.07M)	(467.85M)	[{"date":"2024-09-30","value":-40019200000,"profit":false},{"date":"2024-12-31","value":-40346500000,"profit":false},{"date":"2025-03-31","value":-40760400000,"profit":false},{"date":"2025-06-30","value":-43806800000,"profit":false},{"date":"2025-09-30","value":-46784900000,"profit":false}]
Other Stockholders' Equity	(1.39M)	(1.37M)	-	-	-	[{"date":"2024-09-30","value":-139200000,"profit":false},{"date":"2024-12-31","value":-136900000,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Total Shareholders' equity	66.19M	78.38M	79.03M	48.38M	22.04M	[{"date":"2024-09-30","value":83.75,"profit":true},{"date":"2024-12-31","value":99.18,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":61.23,"profit":true},{"date":"2025-09-30","value":27.89,"profit":true}]

Total Liabilities & Shareholders Equity	97.99M	114.59M	113.13M	92.07M	90.88M	[{"date":"2024-09-30","value":85.51,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":98.72,"profit":true},{"date":"2025-06-30","value":80.35,"profit":true},{"date":"2025-09-30","value":79.31,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	48.24%	(1.99%)	(12.28%)	(3.61%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-4.12,"profit":false},{"date":"2025-06-30","value":-25.46,"profit":false},{"date":"2025-09-30","value":-7.49,"profit":false}]
Non-current Assets	-	0.05%	(0.73%)	(23.98%)	0.90%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":4.99,"profit":true},{"date":"2025-03-31","value":-80.45,"profit":false},{"date":"2025-06-30","value":-2655.94,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	-	17.21%	(1.29%)	(18.75%)	(1.28%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-7.52,"profit":false},{"date":"2025-06-30","value":-108.95,"profit":false},{"date":"2025-09-30","value":-7.42,"profit":false}]

Total Liabilities
Current Liabilities	-	0.82%	(6.35%)	(17.82%)	(12.77%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-779.49,"profit":false},{"date":"2025-06-30","value":-2186.85,"profit":false},{"date":"2025-09-30","value":-1567.28,"profit":false}]
Non-current Liabilities	-	23.94%	(5.49%)	56.75%	80.56%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":29.71,"profit":true},{"date":"2025-03-31","value":-6.81,"profit":false},{"date":"2025-06-30","value":70.44,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Liabilities	-	13.86%	(5.82%)	28.12%	57.58%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":24.06,"profit":true},{"date":"2025-03-31","value":-10.11,"profit":false},{"date":"2025-06-30","value":48.84,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	3.29%	0.95%	0.25%	0.74%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":28.76,"profit":true},{"date":"2025-06-30","value":7.68,"profit":true},{"date":"2025-09-30","value":22.43,"profit":true}]
Retained Earnings	-	0.82%	1.03%	7.47%	6.80%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":10.94,"profit":true},{"date":"2025-03-31","value":13.73,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":90.96,"profit":true}]
Other Stockholders' Equity	-	(1.65%)	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Total Shareholders' equity	-	18.43%	0.83%	(38.77%)	(54.45%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":4.48,"profit":true},{"date":"2025-06-30","value":-210.44,"profit":false},{"date":"2025-09-30","value":-295.51,"profit":false}]

Total Liabilities & Shareholders Equity	-	16.94%	(1.28%)	(18.61%)	(1.29%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-7.53,"profit":false},{"date":"2025-06-30","value":-109.85,"profit":false},{"date":"2025-09-30","value":-7.62,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(19.75M)	(23.56M)	1.06M	(28.57M)	(23.09M)	[{"date":"2020-12-31","value":-1865.25,"profit":false},{"date":"2021-12-31","value":-2224.83,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2697.45,"profit":false},{"date":"2024-12-31","value":-2180.55,"profit":false}]

Investing Activities
Net Investing Cash Flow	13.04M	9.74M	(46.16M)	46.45M	(2.31M)	[{"date":"2020-12-31","value":28.07,"profit":true},{"date":"2021-12-31","value":20.98,"profit":true},{"date":"2022-12-31","value":-99.38,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-4.97,"profit":false}]

Financing Activities
Net Financing Cash Flow	29.86M	36.93M	1.63M	6.42M	35.86M	[{"date":"2020-12-31","value":80.87,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":4.42,"profit":true},{"date":"2023-12-31","value":17.39,"profit":true},{"date":"2024-12-31","value":97.09,"profit":true}]

Net Change in Cash	23.09M	23.09M	(44.34M)	24.06M	10.36M	[{"date":"2020-12-31","value":95.97,"profit":true},{"date":"2021-12-31","value":96,"profit":true},{"date":"2022-12-31","value":-184.32,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":43.07,"profit":true}]

Free Cash Flow
Free Cash Flow	(19.82M)	(23.91M)	646.00K	(29.24M)	(23.66M)	[{"date":"2020-12-31","value":-3067.65,"profit":false},{"date":"2021-12-31","value":-3702.01,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-4526.32,"profit":false},{"date":"2024-12-31","value":-3662.07,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	19.28%	(104.49%)	(2797.45%)	(19.16%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-542.04,"profit":false},{"date":"2023-12-31","value":-14511.04,"profit":false},{"date":"2024-12-31","value":-99.4,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(25.26%)	(573.67%)	(200.63%)	(104.97%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	23.66%	(95.58%)	293.57%	458.26%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":5.16,"profit":true},{"date":"2022-12-31","value":-20.86,"profit":false},{"date":"2023-12-31","value":64.06,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	-	0.03%	(292.00%)	(154.25%)	(56.93%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-963065.14,"profit":false},{"date":"2023-12-31","value":-508746.03,"profit":false},{"date":"2024-12-31","value":-187748.45,"profit":false}]

Free Cash Flow
Free Cash Flow	-	20.68%	(102.70%)	(4626.32%)	(19.09%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-496.64,"profit":false},{"date":"2023-12-31","value":-22371.82,"profit":false},{"date":"2024-12-31","value":-92.33,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(5.79M)	(6.35M)	(4.89M)	(5.54M)	(3.62M)	[{"date":"2024-09-30","value":-578700000,"profit":false},{"date":"2024-12-31","value":-634600000,"profit":false},{"date":"2025-03-31","value":-488600000,"profit":false},{"date":"2025-06-30","value":-553900000,"profit":false},{"date":"2025-09-30","value":-361600000,"profit":false}]

Investing Activities
Net Investing Cash Flow	3.89M	2.63M	1.90M	(14.00K)	(12.00K)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":67.77,"profit":true},{"date":"2025-03-31","value":48.95,"profit":true},{"date":"2025-06-30","value":-0.36,"profit":false},{"date":"2025-09-30","value":-0.31,"profit":false}]

Financing Activities
Net Financing Cash Flow	(3.00K)	21.73M	5.04M	(307.00K)	1.83M	[{"date":"2024-09-30","value":-0.01,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":23.21,"profit":true},{"date":"2025-06-30","value":-1.41,"profit":false},{"date":"2025-09-30","value":8.44,"profit":true}]

Net Change in Cash	(1.86M)	18.05M	1.99M	(5.57M)	(1.80M)	[{"date":"2024-09-30","value":-10.33,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":11.02,"profit":true},{"date":"2025-06-30","value":-30.85,"profit":false},{"date":"2025-09-30","value":-9.96,"profit":false}]

Free Cash Flow
Free Cash Flow	(5.88M)	(6.71M)	(4.98M)	(5.55M)	(3.63M)	[{"date":"2024-09-30","value":-587500000,"profit":false},{"date":"2024-12-31","value":-671100000,"profit":false},{"date":"2025-03-31","value":-498300000,"profit":false},{"date":"2025-06-30","value":-555300000,"profit":false},{"date":"2025-09-30","value":-362800000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	9.66%	(23.01%)	13.36%	(34.72%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":72.28,"profit":true},{"date":"2025-03-31","value":-172.14,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-259.77,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(32.23%)	(27.78%)	(100.74%)	(14.29%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(724566.67%)	(76.79%)	(106.09%)	(697.39%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Net Change in Cash	-	(1068.24%)	(88.98%)	(380.03%)	(67.70%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	14.23%	(25.75%)	11.44%	(34.67%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-180.95,"profit":false},{"date":"2025-06-30","value":80.39,"profit":true},{"date":"2025-09-30","value":-243.62,"profit":false}]

Lineage Cell Therapeutics Inc Ratios

Lineage Cell Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	LCTX
Cash Ratio	4.32
Current Ratio	4.50

Lineage Cell Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	LCTX
ROA (LTM)	-13.65%
ROE (LTM)	-157.75%

Lineage Cell Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	LCTX
Debt Ratio Lower is generally better. Negative is bad.	0.77
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.25

Lineage Cell Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	LCTX
Trailing PE	NM
Forward PE	NM
P/S (TTM)	35.35
P/B	17.35
Price/FCF	NM
EV/R	31.85
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Lineage Cell Therapeutics Inc share price today?

Lineage Cell Therapeutics Inc (LCTX) share price today is $1.72

Can Indians buy Lineage Cell Therapeutics Inc shares?

Yes, Indians can buy shares of Lineage Cell Therapeutics Inc (LCTX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LCTX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Lineage Cell Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Lineage Cell Therapeutics Inc (LCTX) via the Vested app. You can start investing in Lineage Cell Therapeutics Inc (LCTX) with a minimum investment of $1.

How to invest in Lineage Cell Therapeutics Inc shares from India?

You can invest in shares of Lineage Cell Therapeutics Inc (LCTX) via Vested in three simple steps:

Click on Sign Up or Invest in LCTX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Lineage Cell Therapeutics Inc shares

What is Lineage Cell Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Lineage Cell Therapeutics Inc (LCTX) is $2.09. The 52-week low price of Lineage Cell Therapeutics Inc (LCTX) is $0.37.

What is Lineage Cell Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Lineage Cell Therapeutics Inc (LCTX) is

What is Lineage Cell Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Lineage Cell Therapeutics Inc (LCTX) is 17.35

What is Lineage Cell Therapeutics Inc dividend yield?

The dividend yield of Lineage Cell Therapeutics Inc (LCTX) is 0.00%

What is the Market Cap of Lineage Cell Therapeutics Inc?

The market capitalization of Lineage Cell Therapeutics Inc (LCTX) is $386.95M

What is Lineage Cell Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Lineage Cell Therapeutics Inc is LCTX

How Can Investors Use Lineage Cell Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Lineage Cell Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Lineage Cell Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Lineage Cell Therapeutics Inc shares for Indian investors?

When investing in Lineage Cell Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Lineage Cell Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Lineage Cell Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Lineage Cell Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Lineage Cell Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Lineage Cell Therapeutics Inc Share Price

Lineage Cell Therapeutics Inc Analyst Forecast

Lineage Cell Therapeutics Inc Share Price Chart

Lineage Cell Therapeutics Inc Key Stock Metrics

About Lineage Cell Therapeutics Inc, Common Stock

Lineage Cell Therapeutics Inc Stock Returns

Lineage Cell Therapeutics Inc Financials

Lineage Cell Therapeutics Inc Ratios

Lineage Cell Therapeutics Inc Liquidity Ratios

Lineage Cell Therapeutics Inc Asset Efficiency Ratios

Lineage Cell Therapeutics Inc Liability Ratios

Lineage Cell Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Lineage Cell Therapeutics Inc Share Price

Lineage Cell Therapeutics Inc Analyst Forecast

Lineage Cell Therapeutics Inc Share Price Chart

Lineage Cell Therapeutics Inc Key Stock Metrics

About Lineage Cell Therapeutics Inc, Common Stock

Lineage Cell Therapeutics Inc Stock Returns

Lineage Cell Therapeutics Inc Financials

Lineage Cell Therapeutics Inc Ratios

Lineage Cell Therapeutics Inc Liquidity Ratios

Lineage Cell Therapeutics Inc Asset Efficiency Ratios

Lineage Cell Therapeutics Inc Liability Ratios

Lineage Cell Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²